Has locally advanced unresectable or metastatic solid tumor malignancy other than colorectal cancer and has progressed on, or following, standard of care systemic treatment
Has a tumor that demonstrates the presence of Kirsten rat sarcoma (KRAS) G12C mutation
You may not be if
Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
Has known additional malignancy that is progressing or has required active treatment within the past 3 years
Has known active central nervous system metastases and/or carcinomatous meningitis and/or primary brain tumors
Has active infection, other than those permitted per protocol, requiring systemic therapy
Has not adequately recovered from major surgery or has ongoing surgical complications
Clareo Health | A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
